DK1259536T3 - Fremgangsmåder til peptidfremstilling - Google Patents

Fremgangsmåder til peptidfremstilling

Info

Publication number
DK1259536T3
DK1259536T3 DK00956720T DK00956720T DK1259536T3 DK 1259536 T3 DK1259536 T3 DK 1259536T3 DK 00956720 T DK00956720 T DK 00956720T DK 00956720 T DK00956720 T DK 00956720T DK 1259536 T3 DK1259536 T3 DK 1259536T3
Authority
DK
Denmark
Prior art keywords
peptide
cationic
amino acids
methods
sectors
Prior art date
Application number
DK00956720T
Other languages
English (en)
Inventor
Oeystein Rekdal
John Sigurd Svendsen
Mari Wikman
Terese Solstad
Nannan Yang
Original Assignee
Lytix Biopharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1999/002851 external-priority patent/WO2000012542A2/en
Application filed by Lytix Biopharma As filed Critical Lytix Biopharma As
Application granted granted Critical
Publication of DK1259536T3 publication Critical patent/DK1259536T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Semiconductor Lasers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00956720T 1999-08-31 2000-08-31 Fremgangsmåder til peptidfremstilling DK1259536T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB1999/002851 WO2000012542A2 (en) 1998-08-28 1999-08-31 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
GBGB0005702.6A GB0005702D0 (en) 2000-03-09 2000-03-09 Method
PCT/GB2000/003378 WO2001019852A2 (en) 1999-08-31 2000-08-31 Methods of peptide preparation

Publications (1)

Publication Number Publication Date
DK1259536T3 true DK1259536T3 (da) 2009-06-08

Family

ID=9887296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956720T DK1259536T3 (da) 1999-08-31 2000-08-31 Fremgangsmåder til peptidfremstilling

Country Status (14)

Country Link
US (1) US7393824B1 (da)
EP (1) EP1259536B1 (da)
JP (1) JP4902919B2 (da)
AT (1) ATE422502T1 (da)
AU (1) AU781243B2 (da)
CA (1) CA2382544A1 (da)
CY (1) CY1109450T1 (da)
DE (1) DE60041556D1 (da)
DK (1) DK1259536T3 (da)
ES (1) ES2322228T3 (da)
GB (1) GB0005702D0 (da)
NO (1) NO330170B1 (da)
PT (1) PT1259536E (da)
WO (1) WO2001019852A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
BRPI0906404B8 (pt) 2008-01-24 2021-05-25 Univ Louisiana State construção de fusão com domínio lítico, seus usos, composição farmacêutica, bem como processo para reduzir ou inibir seletivamente a proliferação de uma célula que expressa um receptor, ligante ou antígeno
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
WO2013124436A1 (en) * 2012-02-23 2013-08-29 University Of East London Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains
EP4035685A1 (en) 2012-10-30 2022-08-03 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
GB201401877D0 (en) 2014-02-04 2014-03-19 Univ Tromsoe Peptides
WO2016056665A1 (ja) * 2014-10-08 2016-04-14 学校法人慶應義塾 白血球の細胞外トラップ形成の阻害剤
GB201810635D0 (en) * 2018-06-28 2018-08-15 Norut Northern Res Institute As Peptides and cancer treatment
CN111704652B (zh) * 2020-06-02 2022-04-22 昆明医科大学 一种抗光损伤皮肤保护活性多肽om-gl15及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
AU5386996A (en) * 1995-04-05 1996-10-23 Picower Institute For Medical Research, The Agents for binding to advanced glycosylation endproducts, an d methods of their use
JP2001504447A (ja) * 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
DE60041556D1 (de) 2009-03-26
JP4902919B2 (ja) 2012-03-21
JP2003516931A (ja) 2003-05-20
NO20020950L (no) 2002-04-25
ES2322228T3 (es) 2009-06-18
EP1259536B1 (en) 2009-02-11
CA2382544A1 (en) 2001-03-22
ATE422502T1 (de) 2009-02-15
WO2001019852A8 (en) 2004-04-15
US7393824B1 (en) 2008-07-01
WO2001019852A3 (en) 2002-09-12
CY1109450T1 (el) 2014-08-13
NO330170B1 (no) 2011-02-28
AU6858700A (en) 2001-04-17
PT1259536E (pt) 2009-05-14
WO2001019852A2 (en) 2001-03-22
GB0005702D0 (en) 2000-05-03
AU781243B2 (en) 2005-05-12
EP1259536A2 (en) 2002-11-27
NO20020950D0 (no) 2002-02-27

Similar Documents

Publication Publication Date Title
CY1109450T1 (el) Μεθοδοι παρασκευης πεπτιδιων
EP1118660A4 (en) ENZYME PRODUCING PLASMA PROTEIN FRAGMENT HAVING THE EFFECT OF INHIBITING CANCER METASTASE AND PLASMA PROTEIN FRAGMENT FRAGMENTED BY THE ENZYME
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
DE69524415T2 (de) UNGESPLEISSTE VARIANTEN DES gp350/220
WO2004094462A3 (en) Methods of peptide preparation
MXPA02012308A (es) Nuevo interferon para el tratamiento de esclerosis multiple.
ATE309265T1 (de) Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt
IT1294967B1 (it) Composizione immunogenica da tlp
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
WO2001088084A3 (fr) Nouveau polypeptide, superoxyde dismutase 11, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001075002A3 (fr) Nouveau polypeptide, gène de regulation du cycle cellulaire humain 28, et polynucléotide codant pour ce polypeptide
WO2001075012A3 (fr) Nouveau polypeptide, peptide signal humain 10 d'une proteine precurseur de la lipoproteine, et polynucleotide codant pour ce polypeptide
WO2001075057A3 (fr) Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2001064866A1 (fr) Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001075050A3 (fr) Nouveau polypeptide, proteine humaine associee au transport vesiculaire 9, et polynucleotide codant pour ce polypeptide
WO2001075046A3 (fr) Nouveau polypeptide, gene humain de regulation 17 du cycle mitotique, et polynucleotide codant pour ce polypeptide
WO2001081535A3 (fr) Nouveau polypeptide, proteine pax humaine 9.9, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075028A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide